LIG1 is a synthetic lethal target in BRCA1 mutant cancers.
Martires LCM, Ahronian LG, Pratt CB, Das NM, Zhang X, Whittington DA, Zhang H, Shen B, Come J, McCarren P, Liu MS, Min C, Feng T, Jahic H, Ali JA, Aird DR, Li F, Andersen JN, Huang A, Mallender WD, Nicholson HE.
Martires LCM, et al. Among authors: li f.
Mol Cancer Ther. 2025 Jan 27. doi: 10.1158/1535-7163.MCT-24-0598. Online ahead of print.
Mol Cancer Ther. 2025.
PMID: 39868490